{"id":48489,"date":"2022-09-16T15:01:57","date_gmt":"2022-09-16T13:01:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/"},"modified":"2022-09-16T15:01:57","modified_gmt":"2022-09-16T13:01:57","slug":"insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/","title":{"rendered":"Insights on the CRISPR Global Market to 2028 &#8211; Rising Age-related Disorders are Driving Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F4450950%2Fglobal-crispr-market-2022-2028%3Futm_source%3DBW%26utm_medium%3DPressRelease%26utm_code%3D2lkbkl%26utm_campaign%3D1750762%2B-%2BInsights%2Bon%2Bthe%2BCRISPR%2BGlobal%2BMarket%2Bto%2B2028%2B-%2BRising%2BAge-related%2BDisorders%2Bare%2BDriving%2BGrowth%26utm_exec%3Djamu273prd&amp;esheet=52910396&amp;newsitemid=20220916005289&amp;lan=en-US&amp;anchor=%26quot%3BGlobal+CRISPR+Market+2022-2028%26quot%3B&amp;index=1&amp;md5=91faf466a5de7e9675df926736f39afc\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global CRISPR Market 2022-2028&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global CRISPR market is anticipated to grow at a substantial CAGR of 36.8 % during the forecast period.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAddgene\n<\/li>\n<li>\nAstraZeneca PLC\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nCaribou Bioscience Inc.\n<\/li>\n<li>\nCellectics SA\n<\/li>\n<li>\nCrispr Therapeutics AG\n<\/li>\n<li>\nEditas Medicine, Inc.\n<\/li>\n<li>\nGenscript Biotech Corp.\n<\/li>\n<li>\nHorizon Discovery Ltd.\n<\/li>\n<li>\nIntegrated DNA Technologies, Inc.\n<\/li>\n<li>\nIntellia Therapeutics Inc.\n<\/li>\n<li>\nLonza Group Ltd.\n<\/li>\n<li>\nMerck KGaA, Darmstadt\n<\/li>\n<li>\nOrigene Technologies, Inc.\n<\/li>\n<li>\nPrecision Bioscience, Inc.\n<\/li>\n<li>\nSangamo Therapeutics Inc.\n<\/li>\n<li>\nThermo Fisher Scientific\n<\/li>\n<li>\nTransposagen Biopharmaceuticals, Inc.\n<\/li>\n<\/ul>\n<p>\nThe growing age-related disorders, increasing prevalence of lifestyle-oriented diseases and fatalities, and growing drug discovery market are also expected to be the key factors that are driving the growth of the market.\n<\/p>\n<p>\nHowever, there are certain factors that are hampering the growth of the market. Patent infringement and ethical issues associated with the misuse of CRISPR gene editing tools are estimated to hamper the growth of the market.\n<\/p>\n<p>\nThe global CRISPR market is segmented based on the application and end-user. Based on the application, the market is segmented into cell line engineering, CRISPR plasmid, gene database\/gene library, genetic engineering, genetically modified organism or crops, genome editing, and human stem cells. Based on the end-user, the market is sub-segmented into academic institutes, biotechnology companies, pharmaceutical companies, and research and development institutes.\n<\/p>\n<p>\nThe above-mentioned segments can be customized as per the requirements. Among application segments, the CRISPR plasmid is expected to hold a prominent share in the market over the forecast period. The CRISPR-Cas9 system offers over other mutagenic techniques like ZFN and TALEN is the relative simplicity of its plasmid design and construction, which supports the segment growth positively during the forecast period.\n<\/p>\n<p>\nGeographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American region is expected to hold a significant share in the market during the forecast period. Several advancements in CRISPR technology by players in the region are propelling the growth of the market. The advancements in technology will help in reducing errors, limiting unintended effects, improving the accuracy of the tool, widening its applications, developing gene therapies, and more.\n<\/p>\n<p>\n<strong>The Report Covers<\/strong>\n<\/p>\n<ul>\n<li>\nComprehensive research methodology of the global CRISPR market.\n<\/li>\n<li>\nThis report also includes a detailed and extensive market overview with key analyst insights.\n<\/li>\n<li>\nAn exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.\n<\/li>\n<li>\nAnalysis of regional regulations and other government policies impacting the global CRISPR market.\n<\/li>\n<li>\nInsights about market determinants that are stimulating the global CRISPR market.\n<\/li>\n<li>\nDetailed and extensive market segments with the regional distribution of forecasted revenues.\n<\/li>\n<li>\nExtensive profiles and recent developments of market players.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Report Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Market Overview and Insights<\/strong>\n<\/p>\n<p>\n2.1. Scope of the Report\n<\/p>\n<p>\n2.2. Analyst Insight &amp; Current Market Trends\n<\/p>\n<p>\n2.2.1. Key Findings\n<\/p>\n<p>\n2.2.2. Recommendations\n<\/p>\n<p>\n2.2.3. Conclusion\n<\/p>\n<p>\n<strong>3. Competitive Landscape<\/strong>\n<\/p>\n<p>\n3.1. Key Company Analysis\n<\/p>\n<p>\n3.1.1. Overview\n<\/p>\n<p>\n3.1.2. Financial Analysis\n<\/p>\n<p>\n3.1.3. SWOT Analysis\n<\/p>\n<p>\n3.1.4. Recent Developments\n<\/p>\n<p>\n3.2. Key Strategy Analysis\n<\/p>\n<p>\n3.3. Impact of Covid-19 on Key Players\n<\/p>\n<p>\n<strong>4. Market Segmentation<\/strong>\n<\/p>\n<p>\n4.1. Global CRISPR Market by Application\n<\/p>\n<p>\n4.1.1. Cell Line Engineering\n<\/p>\n<p>\n4.1.2. CRISPR Plasmid\n<\/p>\n<p>\n4.1.3. Gene Database\/Gene Library\n<\/p>\n<p>\n4.1.4. Genetic Engineering\n<\/p>\n<p>\n4.1.5. Genetically Modified Organism or Crops\n<\/p>\n<p>\n4.1.6. Genome Editing\n<\/p>\n<p>\n4.1.7. Human Stem Cells\n<\/p>\n<p>\n4.2. Global CRISPR Market by End-User\n<\/p>\n<p>\n4.2.1. Academic Institutes\n<\/p>\n<p>\n4.2.2. Biotechnology Companies\n<\/p>\n<p>\n4.2.3. Pharmaceuticals Companies\n<\/p>\n<p>\n4.2.4. Research and Development Institutes\n<\/p>\n<p>\n<strong>5. Regional Analysis<\/strong>\n<\/p>\n<p>\n<strong>6. Company Profiles<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F4450950%2Fglobal-crispr-market-2022-2028%3Futm_source%3DBW%26utm_medium%3DPressRelease%26utm_code%3D2lkbkl%26utm_campaign%3D1750762%2B-%2BInsights%2Bon%2Bthe%2BCRISPR%2BGlobal%2BMarket%2Bto%2B2028%2B-%2BRising%2BAge-related%2BDisorders%2Bare%2BDriving%2BGrowth%26utm_exec%3Djamu273prd&amp;esheet=52910396&amp;newsitemid=20220916005289&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.researchandmarkets.com%2Fr%2Fmelcn5&amp;index=2&amp;md5=0043c76c87b92694d0366a9e53fc9f61\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/melcn5<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x70;r&#x65;s&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;c&#x68;a&#x6e;d&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#115;&#64;&#114;&#101;sea&#x72;&#x63;&#x68;&#x61;&#x6e;&#100;&#109;&#97;rke&#x74;&#x73;&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global CRISPR Market 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CRISPR market is anticipated to grow at a substantial CAGR of 36.8 % during the forecast period. Companies Mentioned Addgene AstraZeneca PLC Bio-Rad Laboratories, Inc. Caribou Bioscience Inc. Cellectics SA Crispr Therapeutics AG Editas Medicine, Inc. Genscript Biotech Corp. Horizon &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48489","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global CRISPR Market 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CRISPR market is anticipated to grow at a substantial CAGR of 36.8 % during the forecast period. Companies Mentioned Addgene AstraZeneca PLC Bio-Rad Laboratories, Inc. Caribou Bioscience Inc. Cellectics SA Crispr Therapeutics AG Editas Medicine, Inc. Genscript Biotech Corp. Horizon ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-16T13:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Insights on the CRISPR Global Market to 2028 &#8211; Rising Age-related Disorders are Driving Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-16T13:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/\"},\"wordCount\":601,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220916005289\\\/en\\\/1574235\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/\",\"name\":\"Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220916005289\\\/en\\\/1574235\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-16T13:01:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220916005289\\\/en\\\/1574235\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220916005289\\\/en\\\/1574235\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insights on the CRISPR Global Market to 2028 &#8211; Rising Age-related Disorders are Driving Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global CRISPR Market 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global CRISPR market is anticipated to grow at a substantial CAGR of 36.8 % during the forecast period. Companies Mentioned Addgene AstraZeneca PLC Bio-Rad Laboratories, Inc. Caribou Bioscience Inc. Cellectics SA Crispr Therapeutics AG Editas Medicine, Inc. Genscript Biotech Corp. Horizon ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-16T13:01:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Insights on the CRISPR Global Market to 2028 &#8211; Rising Age-related Disorders are Driving Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-09-16T13:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/"},"wordCount":601,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/","name":"Insights on the CRISPR Global Market to 2028 - Rising Age-related Disorders are Driving Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg","datePublished":"2022-09-16T13:01:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220916005289\/en\/1574235\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-crispr-global-market-to-2028-rising-age-related-disorders-are-driving-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Insights on the CRISPR Global Market to 2028 &#8211; Rising Age-related Disorders are Driving Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48489"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48489\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}